£108.47

This is the most expensive it has ever been. Walk away.

£108 today · previous high £108 · all-time low £104

CRC Press Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 47 days · 47 data points (no recent data)

Historical
Generating forecast…
£108.47 £103.09 £104.26 £105.44 £106.61 £107.79 £108.96 25 July 2026 05 August 2026 17 August 2026 28 August 2026 09 September 2026
View at Amazon ↗

Price data last checked 44 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 47 days • 2 price levels

Days at Price
Current Price
8 days 39 days · current 0 10 20 29 39 £104 £108 Days at Price

Price Analysis

Most common price: £108 (39 days, 83.0%)

Price range: £104 - £108

Price levels: 2 different prices over 47 days

Description

Gleaning information from more than 100 experts in the field of cancer diagnosis, prognosis, and therapy worldwide, Cancer Biomarkers: Non-Invasive Early Diagnosis and Prognosis determines the significance of clinical validation approaches for several markers. This book examines the use of noninvasive or minimally invasive molecular cancer markers that are under development or currently in use. It deals with a majority of commonly prevalent cancers and can help anyone working in the health-care industry to recommend or develop early diagnostics, at-risk tests, and prognostic biomarkers for various cancers. It explores the practice of determining biomarkers by their characteristics and relative methodologies, and presents the most recent data as well as a number of current and upcoming early diagnostic noninvasive molecular markers for many common cancers. It also considers the sensitivity and specificity of markers, biomarker market, test providers, and patent information. Approximately 30-35 Cancer Specific Noninvasive Molecular Diagnostic Markers in a Single Volume The book details the general and technical aspects of noninvasive cancer markers. It covers imaging, cutting-edge molecular technologies for biomarker development, and noninvasive or minimally invasive sources of molecular markers, as well as quality control and ethical issues in cancer biomarker discovery. It also provides a detailed account of brain, head and neck, and oral cancer markers, and provides information on a number of gastrointestinal cancers, lung cancer, and mesothelioma markers. Emphasizes the Importance of Volatile Markers in Early Cancer Diagnosis Presents noninvasive early molecular markers in urological cancers Describes gynecological and endocrine cancer markers Details noninvasive markers of breast, ovarian, cervical, and thyroid cancers Addresses hematological malignancies Contains information on noninvasive molecular markers in myelodysplastic syndromes, acute myeloid leukemia, Hodgkin’s lymphoma, and multiple myeloma Provides comprehensive information on diagnostic and prognostic biomarkers in cutaneous melanoma This text considers molecular technologies for biomarker development, noninvasive or minimally invasive sources of molecular markers, and quality control and ethical issues in cancer biomarker discovery.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
31 March 2017
Listed Since
04 April 2017

Barcode

No barcode data available

Similar Products You Might Like

Tumor Biomarker Discovery: Methods and Protocols - Humana
97% match

Tumor Biomarker Discovery: Methods and Protocols - Humana

Humana

£102.47 03 Oct 2026
Advances in Cancer Biomarkers: From biochemistry to clinic for a critical revision: 867 (Advances in Experimental Medicine and Biology, 867)
97% match

Advances in Cancer Biomarkers: From biochemistry to clinic for a critical revision: 867 (Advances in Experimental Medicine and Biology, 867)

Springer

£80.67 11 Sep 2026
Biotargets of Cancer in Current Clinical Practice (Current Clinical Pathology)
97% match

Biotargets of Cancer in Current Clinical Practice (Current Clinical Pathology)

Humana

£141.67 24 Sep 2026
Isolation and Molecular Characterization of Circulating Tumor Cells: 994 (Advances in Experimental Medicine and Biology, 994)
97% match

Isolation and Molecular Characterization of Circulating Tumor Cells: 994 (Advances in Experimental Medicine and Biology, 994)

Springer

£124.36 02 Oct 2026
Molecular Biomarkers for Cancer Diagnosis and Therapy
97% match

Molecular Biomarkers for Cancer Diagnosis and Therapy

Springer

£121.71 26 Aug 2026
Circulating Tumor Cells in Breast Cancer Metastatic Disease: 1220 (Advances in Experimental Medicine and Biology, 1220)
97% match

Circulating Tumor Cells in Breast Cancer Metastatic Disease: 1220 (Advances in Experimental Medicine and Biology, 1220)

Springer

£74.66 18 Sep 2026
Encyclopedia of Cancer and Society
97% match

Encyclopedia of Cancer and Society

Sage Publishing

£187.75 27 Aug 2026
Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology)
97% match

Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology)

Humana

£92.38 11 Sep 2026
Cancer Biomarkers: Clinical Aspects and Laboratory Determination
96% match

Cancer Biomarkers: Clinical Aspects and Laboratory Determination

Elsevier

£110.19 24 Sep 2026
Histological and Serological Tumor Markers and Gene Expression and Their Clinical Usefulness in Cancers
96% match

Histological and Serological Tumor Markers and Gene Expression and Their Clinical Usefulness in Cancers

£145.10 07 Sep 2026
Targeted Therapies in Oncology
96% match

Targeted Therapies in Oncology

CRC Press

£65.09 11 Sep 2026
Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression, 9)
96% match

Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression, 9)

Springer

£179.97 26 Sep 2026
Cancer Biology
96% match

Cancer Biology

Oxford University Press

Price unavailable
Advances in Molecular Pathology, 2018 (Volume 1-1) (Advances, Volume 1-1)
96% match

Advances in Molecular Pathology, 2018 (Volume 1-1) (Advances, Volume 1-1)

Elsevier

£122.20 24 Sep 2026
Oxford Textbook of Cancer Biology - Oxford University Press
96% match

Oxford Textbook of Cancer Biology - Oxford University Press

Oxford University Press

£150.69 22 Oct 2026
Cancer Epigenetics for Precision Medicine: Methods and Protocols: 1856 (Methods in Molecular Biology, 1856)
96% match

Cancer Epigenetics for Precision Medicine: Methods and Protocols: 1856 (Methods in Molecular Biology, 1856)

Humana

£117.75 05 Sep 2026
Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression)
96% match

Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression)

Springer

£158.23 30 Sep 2026
Advances In Precision Medicine: Insights From Oncology Research And Clinical Applications
96% match

Advances In Precision Medicine: Insights From Oncology Research And Clinical Applications

£148.14 05 Sep 2026
Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures: 13 (Cancer Growth and Progression, 13)
96% match

Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures: 13 (Cancer Growth and Progression, 13)

Springer

£148.21 24 Sep 2026
Cancer Consult: Expertise for Clinical Practice - Oncology
96% match

Cancer Consult: Expertise for Clinical Practice - Oncology

Wiley

£118.26 02 Oct 2026